27 related articles for article (PubMed ID: 38471629)
1. Within- and between-subject biological variation estimates for the enumeration of lymphocyte deep immunophenotyping and monocyte subsets.
Guo K; Feng X; Xu L; Li C; Ma Y; Peng M
Clin Chem Lab Med; 2024 May; ():. PubMed ID: 38815136
[TBL] [Abstract][Full Text] [Related]
2. Analytical performance specifications based on biological variation data - considerations, strengths and limitations.
Sandberg S; Coskun A; Carobene A; Fernandez-Calle P; Diaz-Garzon J; Bartlett WA; Jonker N; Galior K; Gonzales-Lao E; Moreno-Parro I; Sufrate-Vergara B; Webster C; Aarsand AK
Clin Chem Lab Med; 2024 Jul; 62(8):1483-1489. PubMed ID: 38501489
[TBL] [Abstract][Full Text] [Related]
3. European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates of β-isomerized C-terminal telopeptide of type I collagen (β-CTX), N-terminal propeptide of type I collagen (PINP), osteocalcin, intact fibroblast growth factor 23 and uncarboxylated-unphosphorylated matrix-Gla protein-a cooperation between the EFLM Working Group on Biological Variation and the International Osteoporosis Foundation-International Federation of Clinical Chemistry Committee on Bone Metabolism.
Cavalier E; Lukas P; Bottani M; Aarsand AK; Ceriotti F; Coşkun A; Díaz-Garzón J; Fernàndez-Calle P; Guerra E; Locatelli M; Sandberg S; Carobene A;
Osteoporos Int; 2020 Aug; 31(8):1461-1470. PubMed ID: 32270253
[TBL] [Abstract][Full Text] [Related]
4. Hyperphosphatemia with elevated serum PTH and FGF23, reduced 1,25(OH)
Kritmetapak K; Losbanos L; Berent TE; Ashrafzadeh-Kian SL; Algeciras-Schimnich A; Hines JM; Singh RJ; Kumar R
BMC Nephrol; 2021 Mar; 22(1):114. PubMed ID: 33784965
[TBL] [Abstract][Full Text] [Related]
5. Biological variation of intact fibroblast growth factor 23 measured on a fully automated chemiluminescent platform.
Jabor A; Kubíček Z; Komrsková J; Vacková T; Vymětalík J; Franeková J
Ann Clin Biochem; 2019 May; 56(3):381-386. PubMed ID: 30813741
[TBL] [Abstract][Full Text] [Related]
6. Dysequilibrium of the PTH-FGF23-vitamin D axis in relapsing remitting multiple sclerosis; a longitudinal study.
Stein MS; Ward GJ; Butzkueven H; Kilpatrick TJ; Harrison LC
Mol Med; 2018 May; 24(1):27. PubMed ID: 30134801
[TBL] [Abstract][Full Text] [Related]
7. European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates for serum biointact parathyroid hormone based on weekly samplings from 91 healthy participants.
Bottani M; Banfi G; Guerra E; Locatelli M; Aarsand AK; Coşkun A; Díaz-Garzón J; Fernandez-Calle P; Sandberg S; Ceriotti F; González-Lao E; Simon M; Carobene A;
Ann Transl Med; 2020 Jul; 8(14):855. PubMed ID: 32793699
[TBL] [Abstract][Full Text] [Related]
8. The biological variation of serum 1,25-dihydroxyvitamin D and parathyroid hormone, and plasma fibroblast growth factor 23 in healthy individuals.
Iannone F; Angotti E; Lucia F; Martino L; Antico GC; Galato F; Aversa I; Gallo R; Giordano C; Abatino A; Mancuso S; Carinci LG; Martucci M; Teti C; Costanzo F; Cuda G; Palmieri C
Clin Chim Acta; 2024 Apr; 557():117863. PubMed ID: 38471629
[TBL] [Abstract][Full Text] [Related]
9. Physiology of the Calcium-Parathyroid Hormone-Vitamin D Axis.
Goltzman D; Mannstadt M; Marcocci C
Front Horm Res; 2018; 50():1-13. PubMed ID: 29597231
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Vitamin D with Peptide Hormones with Emphasis on Parathyroid Hormone, FGF23, and the Renin-Angiotensin-Aldosterone System.
Latic N; Erben RG
Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501215
[TBL] [Abstract][Full Text] [Related]
11. The European Biological Variation Study (EuBIVAS): a summary report.
Carobene A; Aarsand AK; Bartlett WA; Coskun A; Diaz-Garzon J; Fernandez-Calle P; Guerra E; Jonker N; Locatelli M; Plebani M; Sandberg S; Ceriotti F
Clin Chem Lab Med; 2022 Mar; 60(4):505-517. PubMed ID: 34049424
[TBL] [Abstract][Full Text] [Related]
12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
